Sudarshan Pharma Industries Ltd Intrinsic Value
SUDARSHAN · Commodities · Current price ₹42.31
Is Sudarshan Pharma Industries Ltd undervalued?
DocStoX estimates the fair value of Sudarshan Pharma Industries Ltd at ₹12 per share, versus the current market price of ₹42. That puts the stock about -71.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 2 independent methods: Residual income (₹6), Graham floor (₹26). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹6 (bear) to ₹12 (base) to ₹26 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹42 versus an intrinsic value of ₹12, Sudarshan Pharma Industries Ltd currently offers -71.3% of negative margin (i.e. a premium).
More on Sudarshan Pharma Industries Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.